Literature DB >> 17020064

The nose: gatekeeper and trigger of bronchial disease.

G Hens1, P W Hellings.   

Abstract

The nose is strategically placed at the entrance of the airway. Nose breathing takes place under physiologic circumstances and protects the lower airways from exposure to unconditioned air and exogenous particles. Alternatively, nasal disease may have a negative impact on lower airway biology, being involved in aggravation of bronchial disease. The interaction between upper and lower airway disease has been recognized for centuries. Due to the increase in prevalence of allergic diseases during the last decades, new interest has been gained in understanding the mechanisms underlying the interaction between rhinitis and asthma. Nowadays, allergic rhinitis and asthma are considered part of a global airway disease, with both diagnostic and therapeutic consequences for every day clinical practice. Besides allergy, other inflammatory conditions of the upper airways are associated with lower airway disease via unknown mechanisms. Viral rhinitis often coincides with exacerbations of bronchial disease, chronic sinus disease with or without nasal polyps frequently relates to bronchial dysfunction and occupational rhinitis and asthma are often present in the same individuals. In spite of the clinical relevance of considering the airway as one organ with major involvement of disease in upper, lower or both parts, many clues to understand the pathology still remain to be explored. This manuscript aims at providing a comprehensive overview of the current knowledge on the interaction between nasal disease and lower airway biology and stresses the importance of further research on this important matter.

Entities:  

Mesh:

Year:  2006        PMID: 17020064

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  13 in total

1.  Diode laser treatment in therapy-resistant allergic rhinitis: impact on nasal obstruction and associated symptoms.

Authors:  Philipp P Caffier; Hans Scherer; Konrad Neumann; Sven Lück; Harald Enzmann; Andreas Haisch
Journal:  Lasers Med Sci       Date:  2010-07-10       Impact factor: 3.161

2.  Correlation between cytokine levels in nasal fluid and scored clinical parameters in patients with nasal polyposis.

Authors:  Aleksandar Perić; Danilo Vojvodić; Aneta V Perić; Vesna Radulović; Olivera Miljanović
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-01-03

Review 3.  Global airway disease beyond allergy.

Authors:  Peter W Hellings; Emmanuel P Prokopakis
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

4.  Nasal priming by a murine coronavirus provides protective immunity against lethal heterologous virus pneumonia.

Authors:  Xiaoyang Hua; Rahul Vijay; Rudragouda Channappanavar; Jeremiah Athmer; David K Meyerholz; Nitin Pagedar; Stephen Tilley; Stanley Perlman
Journal:  JCI Insight       Date:  2018-06-07

Review 5.  Taste receptors in innate immunity.

Authors:  Robert J Lee; Noam A Cohen
Journal:  Cell Mol Life Sci       Date:  2014-10-17       Impact factor: 9.261

6.  Computed tomographic pulmonary changes in patients with chronic rhinosinusitis.

Authors:  Bruno Hochhegger; Giordano R T Alves; Klaus L Irion; Guilherme Watte; Betina Scheeren; Robson Rottenfuser; Edson Marchiori
Journal:  Br J Radiol       Date:  2015-08-06       Impact factor: 3.039

7.  Prevalence of non-tuberculous mycobacteria in HIV-infected patients admitted to hospital with pneumonia.

Authors:  N C Lapinel; S E Jolley; J Ali; D A Welsh
Journal:  Int J Tuberc Lung Dis       Date:  2019-04-01       Impact factor: 2.373

8.  An intratracheal challenge murine model of asthma: can bronchial inflammation affect the nose?

Authors:  Jiaxing Xie; Yin Xi; Qingling Zhang; Guoqin Chen; Luo Wei; Kefang Lai; Nanshan Zhong
Journal:  Allergy Asthma Immunol Res       Date:  2014-10-17       Impact factor: 5.764

9.  Does quantitative lung SPECT detect lung abnormalities earlier than lung function tests? Results of a pilot study.

Authors:  Pernilla Norberg; Hans Lennart Persson; Birgitta Schmekel; Gudrun Alm Carlsson; Karl Wahlin; Michael Sandborg; Agnetha Gustafsson
Journal:  EJNMMI Res       Date:  2014-08-01       Impact factor: 3.138

10.  Fungal Aflatoxins Reduce Respiratory Mucosal Ciliary Function.

Authors:  Robert J Lee; Alan D Workman; Ryan M Carey; Bei Chen; Phillip L Rosen; Laurel Doghramji; Nithin D Adappa; James N Palmer; David W Kennedy; Noam A Cohen
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.